September 16 2015

Nexvet Biopharma (Nasdaq: NVET), a veterinary biologics developer, has secured a dedicated biologics manufacturing facility in Tullamore which will lead to the creation of up to 30 new roles over the next year. The project is supported by the Department of Jobs, Enterprise & Innovation through IDA Ireland.

BioNua Limited, a wholly-owned subsidiary of Nexvet, will run business operations at the 20,000 square foot facility, which was previously devoted to producing human biopharmaceuticals. The facility has historically operated under an Investigational Medicinal Products License and a cGMP Manufacturing License from Ireland’s Health Products Regulatory Authority and is equipped with cGMP grade clean rooms, water for injection, purified water, and clean steam generation systems. The manufacturing facility is supported by analytical and development laboratories.